Legend Biotech (LEGN) Current Assets (2019 - 2025)

Legend Biotech's Current Assets history runs 7 years deep, the most recent figure standing at $1.2 billion for Q4 2025.

• Quarterly Current Assets fell 2.87% year-over-year to $1.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (down 2.87% YoY) and the FY2025 annual result came in at $1.2 billion, down 2.87% from the prior year.
• Current Assets was $1.2 billion for Q4 2025 at Legend Biotech, roughly flat from $1.2 billion in the prior quarter.
• Across five years, Current Assets topped out at $1.6 billion in Q2 2023 and bottomed at $475074.0 in Q1 2021.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets surged 181849.97% — and 2024, when it fell 14.28%.
• Legend Biotech's Current Assets stood at $949.8 million in 2021, then rose by 15.72% to $1.1 billion in 2022, then soared by 36.27% to $1.5 billion in 2023, then declined by 14.28% to $1.3 billion in 2024, then fell by 2.87% to $1.2 billion in 2025.
• Business Quant data shows LEGN's Current Assets at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.